JP2024536491A5 - - Google Patents

Info

Publication number
JP2024536491A5
JP2024536491A5 JP2024522207A JP2024522207A JP2024536491A5 JP 2024536491 A5 JP2024536491 A5 JP 2024536491A5 JP 2024522207 A JP2024522207 A JP 2024522207A JP 2024522207 A JP2024522207 A JP 2024522207A JP 2024536491 A5 JP2024536491 A5 JP 2024536491A5
Authority
JP
Japan
Prior art keywords
erap1
nucleic acid
seq
inhibitor
complement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024522207A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024536491A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/078037 external-priority patent/WO2023064850A1/en
Publication of JP2024536491A publication Critical patent/JP2024536491A/ja
Publication of JP2024536491A5 publication Critical patent/JP2024536491A5/ja
Pending legal-status Critical Current

Links

JP2024522207A 2021-10-14 2022-10-13 小胞体アミノペプチダーゼ１（ｅｒａｐ１）阻害剤によるぶどう膜炎の治療 Pending JP2024536491A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163255597P 2021-10-14 2021-10-14
US63/255,597 2021-10-14
US202263328008P 2022-04-06 2022-04-06
US63/328,008 2022-04-06
PCT/US2022/078037 WO2023064850A1 (en) 2021-10-14 2022-10-13 Treatment of uveitis with endoplasmic reticulum aminopeptidase 1 (erap1) inhibitors

Publications (2)

Publication Number Publication Date
JP2024536491A JP2024536491A (ja) 2024-10-04
JP2024536491A5 true JP2024536491A5 (enExample) 2025-09-05

Family

ID=84332068

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024522207A Pending JP2024536491A (ja) 2021-10-14 2022-10-13 小胞体アミノペプチダーゼ１（ｅｒａｐ１）阻害剤によるぶどう膜炎の治療

Country Status (5)

Country Link
US (2) US12157891B2 (enExample)
EP (1) EP4416286A1 (enExample)
JP (1) JP2024536491A (enExample)
MX (1) MX2024004558A (enExample)
WO (1) WO2023064850A1 (enExample)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8968731B2 (en) * 2009-10-09 2015-03-03 Csl Limited Treatment of uveitis
US20130315933A1 (en) * 2010-10-06 2013-11-28 Christoph Renner Antibodies Directed Against HLA-B27 Homodimers and Methods and Uses Thereof in Diagnosis and Therapy
TWI619729B (zh) * 2012-04-02 2018-04-01 再生元醫藥公司 抗－ｈｌａ－ｂ*２７抗體及其用途
WO2014155278A2 (en) * 2013-03-26 2014-10-02 Novartis Ag Methods of treating autoimmune diseases using il-17 antagonists
WO2021094763A1 (en) * 2019-11-14 2021-05-20 Grey Wolf Therapeutics Limited Erap1 modulators
IL299986A (en) * 2020-07-25 2023-03-01 Regeneron Pharma Modulation of endoplasmic reticulum aminopeptidase 2 (erap2)-mediated immune response

Similar Documents

Publication Publication Date Title
Tunbridge et al. Catechol‐o‐methyltransferase (COMT) and proline dehydrogenase (PRODH) mRNAs in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and major depression
AU2017224226A1 (en) Compositions and methods of using piRNAs in cancer diagnostics and therapeutics
Papeta et al. Susceptibility loci for murine HIV-associated nephropathy encode trans-regulators of podocyte gene expression
Choi et al. Gene expression and genetic variation data implicate PCLO in bipolar disorder
JP2023531935A5 (enExample)
JP2017532961A5 (enExample)
JP2008526213A (ja) 自己保護オリゴヌクレオチドを使用する、遺伝子発現を調節するための組成物および方法
Hong et al. Maternal human leukocyte antigen-G (HLA-G) genetic variants associate with in utero mother-to-child transmission of HIV-1 in Black South Africans
Løvoll et al. Extrahepatic synthesis of complement components in the rainbow trout (Oncorhynchus mykiss)
JP2023536437A5 (enExample)
KR20170058979A (ko) 헌팅턴병 일배체형에 대한 대립 유전자-특이적 치료
JP2024536491A5 (enExample)
JP2023524824A (ja) Ｋｅｌｃｈドメイン含有７Ｂ（ＫＬＨＤＣ７Ｂ）バリアント及びその使用
JP2023539742A (ja) Ｐｃｓｋ９調節物質及びｌｄｌｒ調節物質による敗血症の治療
Larsen et al. Conservation of A-to-I RNA editing in bowhead whale and pig
CN116889627A (zh) 用固醇调节元件结合转录因子1(srebf1)抑制剂治疗脂质水平升高
CN117255694A (zh) 用磷酸二酯酶3b(pde3b)抑制剂治疗肝病的方法
JP2024535110A5 (enExample)
WO2023278741A1 (en) Methods of treating decreased bone mineral density with kringle containing transmembrane protein 1 (kremen1) inhibitors
JP2024531507A5 (enExample)
Ghazalah et al. Genetic study of I kappa B alpha gene promoter polymorphism associated with hepatitis C virus in Egyptian patients
Niu et al. A 12-bp indel in the 3’UTR of porcine CISH gene associated with Landrace piglet diarrhea score
Niyazova et al. Features of mir-466-3p binding sites in mRNA genes with different functions
JP2022515838A5 (enExample)
US20260027178A1 (en) Treatment Of Parkinson's Disease With SIM BHLH Transcription Factor 2 (SIM2) Agonists